THE CYTOPLASM TRANSLOCATION OF ANDROGEN RECEPTOR COFACTOR P44 AS A TARGET FOR PROSTATE CANCER TREATMENT

$591,772FY2012Department of the ArmyDOD

The Univeristy Of Texas M.D. Anderson Cancer Center

Investigators